Siqi Li
-
- Acute Myeloid Leukemia Research 3
- Periodontics top 10%
-
- Atrial Fibrillation Management and Outcomes 4
- Cardiovascular Effects of Exercise 3
- Viral Infections and Immunology Research 3
- Ophthalmology top 10%
-
- Cancer Immunotherapy and Biomarkers 7
- CAR-T cell therapy research 6
-
- Chronic Obstructive Pulmonary Disease (COPD) Research 4
- Cerebrovascular and Carotid Artery Diseases 3
- Co-authors
- Kazuko TajiriMasaki IedaQiong HuangBaimei HeDongzhu XuNobuyuki MurakoshiWenbin NanKazutaka Aonuma
- Partner nations
- ChinaJapanUnited States
In The Last Decade
Siqi Li
53 papers receiving 589 citations
Peers
Comparison fields: 5 of 103
- Hematology 56
- Periodontics 23
- Cardiology and Cardiovascular Medicine 101
- Ophthalmology 40
- Immunology 78
Countries citing papers authored by Siqi Li
This map shows the geographic impact of Siqi Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Siqi Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Siqi Li more than expected).
Fields of papers citing papers by Siqi Li
This network shows the impact of papers produced by Siqi Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Siqi Li. The network helps show where Siqi Li may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Siqi Li, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 1 | |
| 3 | 2025 | 0 | |
| 4 | 2025 | 0 | |
| 5 | 2025 | 1 | |
| 6 | 2024 | 3 | |
| 7 | 2024 | 3 | |
| 8 | 2024 | 1 | |
| 9 | 2023 | 1 | |
| 10 | 2023 | 4 | |
| 11 | 2022 | 7 | |
| 12 | 2022 | 33 | |
| 13 | 2021 | 34 | |
| 14 | 2021 | 13 | |
| 15 | 2021 | 13 | |
| 16 | 2021 | 2 | |
| 17 | 2020 | 5 | |
| 18 | 2020 | 22 | |
| 19 | 2018 | 5 | |
| 20 | 2012 | 21 |
About Siqi Li
Siqi Li is a scholar working on Cardiology and Cardiovascular Medicine, Critical Care and Intensive Care Medicine and Hematology, having authored 64 papers that have together received 591 indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (7 papers), CAR-T cell therapy research (6 papers), Atrial Fibrillation Management and Outcomes (4 papers), Chronic Obstructive Pulmonary Disease (COPD) Research (4 papers), Cardiovascular Effects of Exercise (3 papers), Acute Myeloid Leukemia Research (3 papers), Cerebrovascular and Carotid Artery Diseases (3 papers) and Viral Infections and Immunology Research (3 papers). The work is most often cited by research in Hematology (56 citations), Periodontics (23 citations) and Cardiology and Cardiovascular Medicine (101 citations). Siqi Li has collaborated with scholars based in China, Japan and United States. Frequent co-authors include Kazuko Tajiri, Masaki Ieda, Qiong Huang, Baimei He, Dongzhu Xu, Nobuyuki Murakoshi, Wenbin Nan, Kazutaka Aonuma, Zhengping Xu and Hui Peng. Their work appears in journals such as Blood, Biomaterials and The Science of The Total Environment.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.